Hematopoietic cell transplantation from unrelated donors as an effective therapy for older patients (> or = 60 years) with active myeloid malignancies

Blood. 2005 May 15;105(10):4147-8. doi: 10.1182/blood-2005-01-0196.
No abstract available

Publication types

  • Letter

MeSH terms

  • Age Factors
  • Aged
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Leukemia, Myeloid, Acute / pathology
  • Leukemia, Myeloid, Acute / surgery
  • Leukemia, Myeloid, Acute / therapy*
  • Middle Aged
  • Myelodysplastic Syndromes / pathology
  • Myelodysplastic Syndromes / surgery
  • Myelodysplastic Syndromes / therapy*
  • Survival Rate
  • Tissue Donors
  • Treatment Outcome